Tesamorelin/Ipamorelin 12/2MG
$120.00
The TESA IPA peptide blend combines Tesamorelin and Ipamorelin to support research on growth hormone release and its effects on metabolism, recovery, and cellular function. Tesamorelin mimics GHRH to stimulate pituitary signaling, while Ipamorelin activates ghrelin receptors for selective GH release.
Together, these peptides act through complementary pathways, allowing researchers to study muscle growth, fat metabolism, sleep regulation, and overall metabolic balance. The blend is supplied as a high-purity lyophilized powder and is intended exclusively for in vitro and laboratory research use.
The TESA IPA peptide blend combines Tesamorelin and Ipamorelin, offering a dual approach to studying growth hormone release and its effects on metabolism, recovery, and cellular function in research applications.
- Tesamorelin mimics GHRH to stimulate pituitary signaling
- Ipamorelin activates ghrelin receptors for selective GH release
- Blend supports studies on muscle growth, fat metabolism, and sleep regulation
Chemical Information
- Chemical Name: Tesamorelin / Ipamorelin Peptide Blend
- Molecular Formula: — (combination of two peptides; exact formula varies by salt form and manufacturer)
- Molecular Weight: Tesamorelin: ~5,136 Da; Ipamorelin: ~711.9 Da
- Peptide Length: Tesamorelin: 44 amino acids; Ipamorelin: 5 amino acids
- Classification: Synthetic peptide blend; GHRH analogue + growth hormone secretagogue (GHS)
- Purity: ≥99% (HPLC, research grade)
- Appearance: White to off-white lyophilized powder
- Net Content: Tesamorelin 12 mg / Ipamorelin 2 mg
Additional Information
- Sequence Description: Tesamorelin: Stabilized GHRH (1–44) analogue; Ipamorelin: Selective ghrelin receptor agonist
- CAS Numbers: Tesamorelin: 218949-48-5; Ipamorelin: 170851-70-4
- Salt Form: Typically acetate or TFA (manufacturer dependent)
Storage Conditions
- Store lyophilized powder at –20 °C or below
- Protect from light, heat, and moisture
- Avoid repeated freeze–thaw cycles after reconstitution
Intended Use
- For research use only (RUO)
- Intended for in vitro and laboratory research applications
- Not for human or veterinary use
The TESA IPA peptide blend combines Tesamorelin, a growth hormone–releasing hormone (GHRH) analog, with Ipamorelin, a selective growth hormone secretagogue. Together, they act through complementary pathways and enhance growth hormone activity in research settings.
Tesamorelin supports pituitary signaling by mimicking natural GHRH, while Ipamorelin binds to ghrelin receptors to trigger GH release without raising cortisol or prolactin. This dual mechanism creates a stronger combined effect than either peptide alone.
Researchers value this blend for studies on metabolic health, lean muscle growth, fat metabolism, sleep quality, recovery, energy balance, and cognition. TESA IPA is produced in precise, lab-grade formulations and supplied exclusively for research and development use.
| Size |
1MG (1000MCG) ,2MG (2000MCG) |
|---|

Reviews
There are no reviews yet.